MedPath

Exploratory study on detecting EGFR mutation including T790M with blood samples from patients with advanced non-small cell lung cancer after EGFR-TKI failure

Not Applicable
Conditions
Advanced non-small cell lung cancer with EGFR mutation
Registration Number
JPRN-UMIN000021860
Lead Sponsor
Shizuoka cancer center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Detection rate of EGFR mutations including T790M in plasma
Secondary Outcome Measures
NameTimeMethod
1) Concordance of EGFR mutation status between tissue samples and plasma 2) Correlation between EGFR mutation status and clinical background
© Copyright 2025. All Rights Reserved by MedPath